Neurostimulation Devices Market Trends 2024

Your Catalyst To a Lucrative Business
Neurostimulation Devices Market Share, Size, Analysis, Growth,
Trends and Forecasts to 2020 | Hexa Research
" Growing geriatric population base and rising
incidences of target diseases such as Alzheimer’s
and Parkinson’s are the major drivers for
Neurostimulation Devices Market."
A recent study by Hexa Research revealed that limited range of treatment choices relating to medical
conditions like epilepsy, Alzheimer’s disease, Parkinson’s disease, migraine headaches, etc. is one of the key
drivers of the global Neurostimulation Devices Market. An upcoming application area is the use of
neurostimulation devices for therapeutic purposes, commonly referred to as neuromodulation. The
neurostimulation devices market is benefitting from technological advancements like the transdermal
neuromodulation technology by Neurowave Medical Technologies and MRI safety-enabled devices by
Medtronics, Inc.
Rising elderly populace - a high risk demographic for Parkinson’s and Alzheimer’s, is also driving market growth.
Accelerated demand for neurostimulation devices in the future years is expected to result from untapped
market opportunities in emerging economies of Asia as well as Latin America and the growing number of
externally funded clinical programs for development of new products.
Browse Details of Report @ https://www.hexaresearch.com/research-report/neurostimulation-devicesindustry/
Follow Us:
Your Catalyst To a Lucrative Business
Hexa Research identifies spinal cord stimulation devices, vagus nerve stimulation devices, gastric electric
stimulation devices, deep brain stimulation devices, and sacral nerve stimulation devices to be the key product
segments in the neurostimulation devices market. Spinal cord stimulation devices, with a contribution of more
than half to the total revenues, were the dominant product segment in 2012.
Pain management proved to be the largest application of neurostimulation devices in 2012 and contributed
more than 65% to the total demand that year. This was chiefly due to high incidence of conditions
characterized by chronic pain and notable therapeutic effects offered by neurostimulation devices.
While North America contributed around 64% to the total revenues in 2012, Asia Pacific is likely to grow the
fastest in future. Fast-developing economies like India and China will result in the Asia Pacific neurostimulation
devices market growing at CAGR higher than 16% from 2013 to 2020.
Hexa Research observes that the neurostimulation devices industry exhibits outsourcing of expensive
manufacturing activities. This enables industry participants to achieve cost efficiency and better profitability.
Key industry players include Boston Scientific Corporation, Cyberonics, Medtronic Inc., an d St. Jude Medical.
Browse Related Category Market Reports @ https://www.hexaresearch.com/research-category/healthcareindustry
Follow Us:
Your Catalyst To a Lucrative Business
Table of Content of Neurostimulation Devices Market
Chapter 1. Executive Summary
1.1. Neurostimulation Devices – Industry Summary and Critical Success Factors (CSFs)
Chapter 2. Neurostimulation devices Industry Outlook
2.1. Market Segmentation
2.2. Market Size and Growth Prospects
2.3. Neurostimulation devices Market Dynamics
2.4. Key Opportunities Prioritized
2.5. Industry Analysis - Porter's
2.6. Neurostimulation Devices - Company Market Share Analysis
2.7. Neurostimulation Devices Market PESTEL Analysis, 2012
Chapter 3. Neurostimulation Devices Product Outlook
3.1. Deep Brain Stimulation Device
3.2. Gastric Electric Stimulation Device
3.3. Spinal Cord Stimulation Device
3.4. Sacral Nerve Stimulation Device
3.5. Vagus Nerve Stimulation Device
Chapter 4. Neurostimulation Devices Application Outlook
4.1. Pain Management
4.2. Epilepsy
4.3. Essential Tremor
4.4. Urinary and Fecal Incontinence
4.5. Depression
4.6. Dystonia
4.7. Gastroparesis
4.8. Parkinson's Disease
4.9. Others
Chapter 5. Neurostimulation Devices Regional Outlook
5.1. North America
5.2. Europe
5.3. Asia Pacific
5.4. RoW
Chapter 6. Competitive Landscape
6.1. Revenue Analysis
6.2. Product Benchmarking
6.3. Strategic Development
Chapter 7. Methodology and Scope
7.1. Research Methodology
Follow Us:
Your Catalyst To a Lucrative Business
7.2. Research Scope & Assumption
7.3. List of Data Sources
Companies Analyzed
Medtronic Inc.
Codman and Shurtleff Inc.
Cervel Neurotech, Inc.
Cyberonics Inc.
Integra Life Sciences
St. Jude Medical
Nevro Corporation
Boston Scientific Corporation
Uroplasty Inc.
Neuronetics, Inc.
IntraPace Inc.
Follow Us:
Your Catalyst To a Lucrative Business
About Us:
Hexa Research is a market research and consulting organization, offering industry reports, custom research
and consulting services to a host of key industries across the globe. We offer comprehensive business
intelligence in the form of industry reports which help our clients obtain clarity about their business
environment and enable them to undertake strategic growth initiatives.
Contact Us:
Ryan Shaw
Hexa Research
Felton Office Plaza
6265 Highway 9
Felton, California 95018
United States
Phone: +1-800-489-3075
Email: [email protected]
Website - http://www.hexaresearch.com/
Follow Us:

Growing geriatric population base and rising incidences of target diseases such as Alzheimer’s and Parkinson’s are the major drivers for this market.